Biomet, Inc. announced today financial results for its third fiscal quarter ended February 28, 2013.
•Net sales increased 9% (9% constant currency) worldwide to approximately $772 million
•Net sales, excluding the Trauma Acquisition, were flat (increased 1% constant currency) worldwide
•S.E.T. sales increased 71% (73% constant currency) worldwide to $161 million and increased 62% in the U.S.
